Clinical dimensions of fibromyalgia symptoms and development of a combined index of severity: The CODI index

BackgroundAlthough a large body of work indicates that fibromyalgia (FM) is not a discrete entity, few studies have attempted to classify the heterogeneity of FM symptoms. The objectives of the present study were to confirm the existence of two latent dimensions underlying FM symptoms (Core-FM symptoms and Distress) by means of factor analysis techniques, and to develop and validate a new combined index of symptom severity (the CODI).MethodsWe analyzed and combined the baseline scores on six visual analog scales of the FIQ (pain, general fatigue, morning fatigue, stiffness, anxiety, and depression) and on the STAI-T (trait anxiety) of 216 Spanish patients diagnosed with FM (97.7% women) who were participating in a randomized, controlled trial.ResultsThe principal component analysis indicated the presence of two correlated factors (labeled as Core-FM symptoms and Distress) that explained 64% of total variance. The subsequent confirmatory factor analysis yielded more empirical support for the two-factor model than the one-factor model (all items loading on one latent dimension). The two factors possessed adequate internal consistency and construct validity given the pattern of significant correlations with the Euroqol items. The Core-FM dimension had a stronger relationship with mobility, self-care, usual activities, and pain/discomfort than with anxiety/depression, whereas the Distress dimension showed the opposite pattern. Finally, summing the standardized scores of the two dimensions, a new combined index of symptom severity (the CODI) was developed.ConclusionThe clinical implications and utility of the CODI are discussed in relation to previous research on FM.

[1]  M. Vallejo,et al.  Development of a self-reporting tool to obtain a Combined Index of Severity of Fibromyalgia (ICAF*) , 2010, Health and quality of life outcomes.

[2]  R M Bennett,et al.  The fibromyalgia impact questionnaire: development and validation. , 1991, The Journal of rheumatology.

[3]  T. Stratz,et al.  Beeinflusst die Depressivität den Behandlungseffekt von Tropisetron bei Fibromyalgiepatienten? , 2003, Zeitschrift für Rheumatologie.

[4]  M. Sullivan,et al.  Targeted treatment of catastrophizing for the management of chronic pain , 2002 .

[5]  M. Mouttapa,et al.  Symptom Clusters in Fibromyalgia: Potential Utility in Patient Assessment and Treatment Evaluation , 2009, Nursing research.

[6]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[7]  R. Bennett.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. , 2005, Clinical and experimental rheumatology.

[8]  L. Crofford,et al.  Chronic widespread pain and fibromyalgia: what we know, and what we need to know. , 2003, Best practice & research. Clinical rheumatology.

[9]  R. P. McDonald,et al.  Choosing a multivariate model: Noncentrality and goodness of fit. , 1990 .

[10]  J. Luciano,et al.  Effectiveness of a psycho-educational program for improving quality of life of fibromyalgia patients , 2008, BMC Musculoskeletal Disorders.

[11]  H. Kaiser.  An index of factorial simplicity , 1974 .

[12]  J. Epping-Jordan,et al.  Innovative care for chronic conditions: building blocks for action , 2002 .

[13]  D. Turk,et al.  Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. , 1996, The Journal of rheumatology.

[14]  Richard A. Kass,et al.  The Latent Structure of the Need Satisfying Properties of Leisure Activities , 1979 .

[15]  H. Hadjistavropoulos,et al.  Measures of anxiety: is there a difference in their ability to predict functioning at three‐month follow‐up among pain patients? , 2004, European journal of pain.

[16]  P. Grossman,et al.  Mindfulness Training as an Intervention for Fibromyalgia: Evidence of Postintervention and 3-Year Follow-Up Benefits in Well-Being , 2007, Psychotherapy and Psychosomatics.

[17]  E. Calandre,et al.  Subgrouping patients with fibromyalgia according to the results of the fibromyalgia impact questionnaire: a replication study , 2011, Rheumatology International.

[18]  X. Badia,et al.  [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. , 1999, Medicina clinica.

[19]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[20]  D. Turk,et al.  Heterogeneity Within the Fibromyalgia Population: Theoretical Implications of Variable Tender Point Severity Ratings , 2009, The Journal of Rheumatology.

[21]  D. Yeshurun,et al.  Cardiovascular response to upright tilt in fibromyalgia differs from that in chronic fatigue syndrome. , 2001, The Journal of rheumatology.

[22]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[23]  J. Rivera,et al.  The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. , 2004, Clinical and experimental rheumatology.

[24]  L. Carmona,et al.  Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. , 2008, Clinical and experimental rheumatology.

[25]  Scott R. Bishop,et al.  The Pain Catastrophizing Scale: Development and validation. , 1995 .

[26]  X. Badia,et al.  Using the EuroQol 5-D in the Catalan General Population: Feasibility and Construct Validity , 1998, Quality of Life Research.

[27]  R. Snaith,et al.  What do anxiety scales measure? , 1996, Acta psychiatrica Scandinavica.

[28]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[29]  M. Bartlett.  A Note on the Multiplying Factors for Various χ2 Approximations , 1954 .

[30]  D. Nampiaparampil,et al.  A review of fibromyalgia. , 2004, The American journal of managed care.

[31]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[32]  Richard G. Lomax,et al.  A Beginner's Guide to Structural Equation Modeling , 2022 .

[33]  B. Gerdle,et al.  Quantitative Sensory Testing in Fibromyalgia Patients and in Healthy Subjects: Identification of Subgroups , 2001, The Clinical journal of pain.

[34]  R. Darlington,et al.  Factor Analysis , 2008 .

[35]  W. Müller,et al.  [The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia]. , 2003, Zeitschrift fur Rheumatologie.

[36]  M. Bartlett,et al.  A note on the multiplying factors for various chi square approximations , 1954 .

[37]  J. Luciano,et al.  Effectiveness of a Psychoeducational Treatment Program Implemented in General Practice for Fibromyalgia Patients: A Randomized Controlled Trial , 2011, The Clinical journal of pain.

[38]  Nancy Julien,et al.  Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study , 2009, Rheumatology International.